Results 141 to 150 of about 14,766 (232)

Euratom Bulletin September 1963 No. 3 [PDF]

, 1963

core  

Clinical outcomes by bone metastasis uptake pattern in differentiated thyroid cancer. [PDF]

BMC Cancer
Wang G, Feng F, Huang S, Li C.
europepmc   +1 more source

Rapid Radiochemical Analysis of Radionuclides Difficult to Measure in Environmental and Waste Samples [PDF]

, 2012
Hou, Xiaolin, Qiao, Jixin, Shi, Keliang
core  

Camrelizumab and apatinib in Chinese patients with locally advanced or metastatic radioiodine-refractory differentiated thyroid cancer: an exploratory open-label, single-arm trial. [PDF]

BMC Med
Zhang X, Sun D, Zhang Y, Mu Z, Shi C, Sun Y, Cheng X, Meng C, Wei X, Liang J, Lin Y.   +10 more
europepmc   +1 more source

Expanding the P2X7R toolbox: discovery of a novel Iodine-125 radioligand. [PDF]

Purinergic Signal
Tempra G, Matera C.
europepmc   +1 more source

[Establishment of the maximum permissible levels of iodine radioisotopes].

Gigiena i sanitariia, 1986
I A, Zvonova, I A, Likhtarev
openaire   +1 more source

Radioactive Iodine Therapy for Pediatric Graves' Hyperthyroidism. [PDF]

Med Sci Monit
Hu RT, Li B.
europepmc   +1 more source

First-in-Human Study of [²¹¹At]NaAt as Targeted α-Therapy in Patients with Radioiodine-Refractory Thyroid Cancer (Alpha-T1 Trial). [PDF]

J Nucl Med
Watabe T, Mukai K, Naka S, Sasaki H, Kamiya T, Hayakawa T, Fukuhara A, Takano T, Shirakami Y, Ooe K, Shigeno S, Okamura S, Masumura K, Hida E, Haba H, Toyoshima A, Isohashi K, Shimomura I, Tomiyama N.   +18 more
europepmc   +1 more source

Predictive factors for the efficacy of radioiodine therapy in patients with Graves' disease. [PDF]

Nucl Med Commun
Iwanaga H, Fujita N, Abe S, Ito R, Abe Y, Minamimoto R, Nishii R, Naganawa S, Kato K.   +8 more
europepmc   +1 more source

The use of radiopharmaceuticals in targeted cancer therapy: a narrative review. [PDF]

Int J Physiol Pathophysiol Pharmacol
Khalaji A, Rostampour M, Riahi F, Rafieezadeh D, Dormiani Tabatabaei SA, Fesharaki S, Tooyserkani SH.   +6 more
europepmc   +1 more source